clonidine
Commercial- Indications
- ADHD
Company intelligence / Profile preview
Lachlan Pharma Holdings Unlimited Company is an Irish-based holding and pharmaceutical company, active since January 2014. It is best known for its exclusive distribution agreement with Concordia Healthcare Corp. for the commercialization of Ulesfia® Lotion in the United States, a treatment for head lice. The company operates primarily as a holding and licensing entity rather than a drug development or R&D-driven biotech firm. There are no public records indicating ongoing clinical trials beyond this commercial activity, nor evidence of proprietary drug discovery platforms or broad pipelines.
5 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lachlan Pharma Holdings Unlimited Company.